Maze meets own expectations in Phase 2 kidney disease trial in the same arena as Vertexnews2026-03-25T11:02:18+00:00March 25th, 2026|Endpoints News|
Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis’ Scemblixnews2026-03-25T10:47:34+00:00March 25th, 2026|Endpoints News|
Philips launches IntraSight Plus to simplify coronary interventions and advance precision carenews2026-03-25T10:03:35+00:00March 25th, 2026|Medical Device News Magazine|
Gilgamesh’s psychedelics pipeline gets $60M backing after AbbVie dealnews2026-03-25T10:00:55+00:00March 25th, 2026|Endpoints News|
